Download Insulin

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Epidemiology of metabolic syndrome wikipedia , lookup

Alzheimer's disease research wikipedia , lookup

Gestational diabetes wikipedia , lookup

Artificial pancreas wikipedia , lookup

Transcript
Diabetes & selected
medications
Medical-surgical Nursing Chapter 64-Iggy-Pg 1300
NUR 152
Mesa Community College
Learning Outcomes

Describe how insulin works in the body and the effects of too little or no
insulin production in the body

Differentiate between type 1 and type 2 diabetes mellitus

Explain the complications that can result from diabetes mellitus

Use the nursing process to create nursing care plans for diabetic patients

Administer the prototype drug metformin safely and effectively

Differentiate between rapid, fast, intermediate, and long acting insulin

Review the appropriate steps when mixing insulin

Understand the nursing implications when administering insulin

Review the proper techniques in blood glucose monitoring

Identify diabetic patients in a state of hyperglycemia or hypoglycemia, and
those at risk for these conditions

Describe diabetic foot care

Describe managing complications from diabetes
Insulin in the body (Pg 1302)
 Insulin
is needed to move glucose into body tissues
 Absence of insulin makes the body break down fat
and protein for energy
 Absence of insulin ↑ the levels of other hormones in
order to attempt to make glucose from other
sources
 Resulting in hyperglycemia (high blood glucose
levels)
 Polyuria
 Polydipsia
 Polyphagia
Type I Diabetes (DM I) (Pg 1306)

Autoimmune disorder where the beta cells are
destroyed in the pancreas leading to no insulin
production

Genetically handed down (tissue type HLA-DR or
HLA-DQ)

Antibodies exist to work against beta cells and
insulin

Usually younger onset
Type II Diabetes (DM II) (Pg 1306)
*See pg 761 in Iggy as well

Insulin resistance and decreased insulin production

Most are obese

Hereditary plays a major role

Gene defects may also play a role

*Metabolic Syndrome (any 3)
 Abdominal
obesity
 Hyperglycemia
 Hypertension
 Hyperlipidemia
Chronic Complications of Diabetes
(Pg 1303-1306)
 Macrovascular
Complications
 Cardiovascular
Disease
 Cerebrovascular Disease
 Microvascular
 Eye
Complications
& Vision
 Diabetic Neuropathy
 Diabetic Nephropathy
 Male ED
 Cognitive Dysfunction
Nursing Process & Diabetes
 Assessment
 Health
History
 Laboratory
Results
 Screening
 Ongoing
 Urine
Assessment
Tests
Nursing Diagnoses
 Risk
for injury r/t hyperglycemia
 Potential
for impaired wound healing r/t
endocrine and vascular effects of diabetes
 Risk
for injury r/t diabetic neuropathy
 Acute
pain r/t diabetic neuropathy
 Chronic
 Risk
pain r/t diabetic neuropathy
for injury r/t diabetic retinopathyreduced vision
Outcomes (Goals)

Performs treatment regimen as prescribed

Follows recommended diet

Monitors blood glucose using correct testing
procedure

Manages symptoms of hyper/hypoglycemia

Seeks health care if blood glucose levels go
outside of recommended parameters

Meets recommended activity levels

Uses medications as prescribed

Maintains optimum weight
Oral Therapy
 Drug
(Pg 1310-1312 Chart 64-2)
Therapy: DM II (Anti-diabetic, oral, Biguanide)
 metformin
(Glucophage)
 Recommended
 Inhibits
as initial therapy in type 2 diabetes mellitus
hepatic glucose production
 Increases
sensitivity of tissue to insulin
 Not
given to people with kidney disease or elevated
creatinine levels
 Look
up in SkyScape as well!
Insulin- Where does it come from and
why do we need it?

Pancreas - Beta cells in islets of Langerhans produce:

Insulin - needed for metabolism of carbs, fats,
proteins (helps move glucose into cells)

Glucagon - stimulates conversion of glycogen to
glucose in the liver

Normal adult blood sugar - 70 to 110 mg/dL
Nursing Implications

Insulin
 Check
 Roll
blood glucose level before giving insulin
vials between hands instead of shaking them to mix
suspensions
 Ensure
 Only
correct storage of insulin vials
use insulin syringes, calibrated in units, to measure
and give insulin
 Ensure
correct timing of insulin dose with meals
 Insulin
order and dosages are second-checked with another nurse
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
12
Insulin (Pg 1313-1315)
Rapid Acting

Novolog (aspart)/Humalog (lispro)

Rapid Acting-Clear

Given right before a meal

Onset: 15-30 minutes

Peak:
 1-3
½

hrs (aspart)
to 1&1/2 hours (lispro)
Duration:
 3-5
5
hours (aspart)
hours (lispro)
Short Acting

Regular (Humulin R/Novolin R)

Short Acting-Clear
 Given
½ to 1 hour before a meal
 Onset:
 Peak:
30 minutes
2 to 5 hours
 Duration:
up to 7-8 hours
Insulin (continued)
Intermediate Acting

Humulin N/Novolin N (isophane)-NPH
(Neutral Protamine Hagedorn)

Intermediate Acting
 Onset:
 Peak:
1&1/2 – 4 hours
4-14 hours
 Duration:

Cloudy
10-24 hours
Insulin (continued)
Long Acting

Lantus (glargine)

Levemir (determir)

Long Acting

Long Acting
 Onset:
 Peak:
2 – 4 hrs
None
 Duration:
 Never
24 hrs
mixed with another
insulin!
 Usually
 Onset:
 Peak:
given twice a day
1 hours
6-8 hours
 Duration
 Never
~ 5 to 24 hours
mixed with another
insulin!
Mixing Insulin

ATI Skills Diabetes
Management
 Step
by Step
Viewing
 Mixing
 Soft
insulin
Fundies
Sliding-Scale Insulin Dosing
Subcutaneous short-acting or regular insulin
doses adjusted according to blood glucose test
results
 Typically used in hospitalized diabetic patients
or those on total parenteral nutrition (TPN) or
enteral tube feedings
 Subcutaneous insulin is ordered in an amount
that increases as the blood glucose increases
 Disadvantage: delays insulin administration
until hyperglycemia occurs; results in large
swings in glucose control

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
19
Sliding scale example

Regular Insulin sliding scale subcutaneous
with meals and at bedtime

151-200= 2 units

201-250= 4 units

251-300= 6 units

301-350= 8 units

351-400=10 units

>400=Call prescriber
Patient Education

Blood Glucose Monitoring

Target goals - Daily sugars

HgbA1C (pg 1308-9)

Technique

Rotating sites

Timing

Recording

Recognizing and reporting results & problems
Glucose-Elevating Drugs

Oral forms of concentrated glucose
 Buccal
tablets, semisolid gel

50% dextrose in water (D50W)

Glucagon
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
24
Interventions (cont): (1330-1332)
Nutrition Therapy
Exercise Therapy

Nutrition Principles

Regular Exercise

Carbohydrate intake

Diabetic Adjustments

Dietary fat &
cholesterol

Safety Assessment

Protein

Special considerations
Preventing Injury from Peripheral
Neuropathy
 Foot
Care
(Chart 64-6)
Preventing foot injuries
 Keeping blood sugars in check

Foot inspection (Chart 64-5)
 Good fitting shoes
 Proper nail trimming



Do not go barefoot!
See your physician immediately for any break in skin
Managing complications
Managing Neuropathic Pain
Reduced Vision

Anticonvulsants

Blood Glucose control

Antidepressants

Regular eye exams

Creams

Environmental management

Maintain Stable Glucose

Large print

Bed cradle

Low vision aids

Good lighting

Audio tools

Syringe magnifiers